Cartesian Therapeutics Inc (RNAC)
Cost of Revenue
$0.00
Quarterly · Period ending: · USD
RNAC Cost of Revenue
Latest reported$0.00period ending
Latest reported$0.00period ending
RNAC Quarterly Cost of Revenue ($0.00 → $0.00)
Quarterly cost of revenue
High-resolution chart · PNG
RNAC cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 12,797,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 13,002,000 | |
| 17,782,000 | |
| 18,624,000 | |
| 607,000 | |
| 539,000 | |
| 498,000 | |
| 644,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |